A California state court judge ruled in favor of a California resident represented by Baum, Hedlund, Aristei & Goldman, allowing her lawsuit against Medtronic to move forward. This is good news for patients across the country who received the Medtronic INFUSE® Bone Graft medical device procedure in an off-label manner, not approved by the FDA.
Lawyers Investigate Hospitals Where Spine Surgeries Caused Patients Severe Pain, Excessive Bone Growth and Other Complications
Baum Hedlund’s first Infuse case involves back surgery patient, April Cabana, who originally sued Medtronic, in addition to Stryker Biotech, her doctor, and Pomona Valley Hospital Medical Center, on July 13, 2011 after two different medical devices implanted during two different back surgeries resulted in debilitating and permanent injuries to her spine.
Baum Hedlund has Defeated Preemption In Ms. Cabana’s Case Three Times
1. August 20, 2012 re Medtronic Infuse
2. September 9, 2013 re Medtronic Infuse
3. September 9, 2013 re Stryker OP-1 Putty